Payer+Provider's Health System Review
Eliquis, Jardiance and Xarelto lead CMS list of drugs subject to negotiation
Despite Democrats’ Celebratory Mood, It’s A Sad Day For American Patients.
August 29, 2023
The move represents an unprecedented step in a long political war over the nation’s exorbitant drug costs.
Read the full post on Health